Literature DB >> 12540604

T-cell compartments of prediabetic NOD mice.

Stuart P Berzins1, Emily S Venanzi, Christophe Benoist, Diane Mathis.   

Abstract

Given the importance of the NOD mouse as a model of type 1 diabetes, there is a surprising lack of published information on the overall composition of the thymic and peripheral T-cell compartments. In this study, we revisited some earlier reports of T-cell abnormalities in this strain and examined a number of additional parameters to provide a global view of T-cells in prediabetic NOD mice. In some cases, we concur with past conclusions, but in other important areas, we find that NOD mice closely resemble nonautoimmune strains. Specifically, and contrary to published reports, the thymocyte subset distribution, the rate and composition of thymic export, and the composition of the peripheral T-cell pool, including the proportion of CD25(+)CD4(+) T-cells, are essentially normal in prediabetic NOD mice. These factors are therefore unlikely to be involved in the loss of tolerance that leads to autoimmunity within this strain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540604     DOI: 10.2337/diabetes.52.2.327

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

Review 1.  The concept of space and competition in immune regulation.

Authors:  Brigitta Stockinger; Thomas Barthlott; George Kassiotis
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

2.  Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.

Authors:  Cristina Ferreira; Yogesh Singh; Anna L Furmanski; F Susan Wong; Oliver A Garden; Julian Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

3.  A model for personalized in vivo analysis of human immune responsiveness.

Authors:  Hannes Kalscheuer; Nichole Danzl; Takashi Onoe; Ted Faust; Robert Winchester; Robin Goland; Ellen Greenberg; Thomas R Spitzer; David G Savage; Hiroyuki Tahara; Goda Choi; Yong-Guang Yang; Megan Sykes
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

4.  Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.

Authors:  René Maehr; Justine D Mintern; Ann E Herman; Ana-Maria Lennon-Duménil; Diane Mathis; Christophe Benoist; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

5.  Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.

Authors:  Ayelet Kaminitz; Keren Mizrahi; Shifra Ash; Avi Ben-Nun; Nadir Askenasy
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 6.  Regulatory T cells in experimental autoimmune disease.

Authors:  Elisabeth Suri-Payer; Benedikt Fritzsching
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

7.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

8.  The role of regulatory T cell defects in type I diabetes and the potential of these cells for therapy.

Authors:  David Thomas; Paola Zaccone; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2005-05-10

Review 9.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

10.  Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity.

Authors:  Rémi J Creusot; C Garrison Fathman
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.